If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTsp Advanced Technologies Plc Regulatory News (TSP.PL)

Share Price Information for Tsp Advanced Technologies Plc (TSP.PL)

Share Price is delayed by 15 minutes
Get Live Data
0.36    0.00 (0.00%)
Bid:
0.22
Ask:
0.50
Spread: 0.28 (127.273%)
Market Cap: £674.28k
TSP.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Tsp Advanced Technologies Plc Share Chart

Bitcoin Treasury Policy

25 Jun 2025 07:00

RNS Number : 2599O
TruSpine Technologies PLC
25 June 2025
 

25 June 2025

TruSpine Technologies plc

("TruSpine" or the "Company")

 

Bitcoin Treasury Policy

 

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it actively pursuing the implementation of a Bitcoin Treasury Policy. The Company will continue to focus on its core business, whilst growing a bitcoin treasury to facilitate the funding of such business over the medium-term.

 

The Company's Bitcoin Treasury Policy will align with the Directors' views that bitcoin provides a means to preserve value over time and serve as a hedge against both inflation and geopolitical events. The Company intends to strategically allocate capital generated from future fundraisings, with the aim of maintaining a treasury consisting of both traditional cash reserves and bitcoin.

 

The Company is exploring potential fundraising opportunities for this purpose, following which, the Directors anticipate being in a position to potentially commence bitcoin acquisitions in due course.

 

Relevant material changes to its bitcoin treasury holdings and further updates on the Bitcoin Treasury Policy will be announced by the Company in due course.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

 

-END-

TruSpine Investor Hub 

https://investorhub.truspinetech.com

TruSpine Technologies Plc

Tel: +44 (0)20 7118 0852

Geoff Miller, Non-executive Chairman

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

Peterhouse Capital Limited (Broker & Financial Adviser)

 Tel: +44 (0)20 7469 0930

Lucy Williams / Duncan Vasey

 

Novus Communications (PR and IR)

Tel: +44 (0)1273 704 473

Alan Green / Jacqueline Briscoe

 J.Briscoe@novuscomms.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXSEEFALEISEDM
12
Date   Source Headline
21st Feb 20243:57 pmRNSNotice of Adjourned AGM
19th Feb 20247:00 amRNSFDA Update
14th Feb 20247:00 amRNSConvertible Loan, Loan Update, AGM Update and RPT
5th Jan 20247:00 amRNSLoan, Related Party Transaction and FDA Update
28th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSCompany Update
30th Oct 20237:00 amRNSFurther re: FDA Update
25th Oct 20238:37 amRNSIP Registration
12th Oct 20237:00 amRNSFurther re: FDA Update
3rd Oct 20237:00 amRNSFurther re: FDA Update
29th Sep 20237:00 amRNSFinal Results
18th Sep 20237:00 amRNSProposed Director Appointments & Update
17th Aug 20231:39 pmRNSResult of Aquis Disciplinary Investigation
15th Aug 20237:00 amRNSSubscription
25th Jul 20237:00 amRNSFurther re: FDA Update
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.